ACE lecture

Gene therapy for hemophilia: a cure for the royal disease?

Already 20 years ago, the first study on gene therapy for the bleeding disorder hemophilia B was published. Internist-hematologist Prof Dr Frank Leebeek explains what has happened since then. Is gene therapy the cure for the royal disease?

Berit Sinterniklaas
Leestijd < 1 min

In this webinar Prof Frank Leebeek reports the latest results on efficacy, side effects, and hurdles of gene therapy for hemophilia A and B.

Academic Centers of Excellence

This video is part of a series of online lectures about the Erasmus MC Academic Centers of Excellence. Prof Frank Leebeek is affiliated with the Academic Center for Breast Cancer.

Lees ook

Nieuwsbrief

Blijf op de hoogte van nieuws en verhalen uit het Erasmus MC en schrijf u in voor onze nieuwsbrief.